Results 41 to 50 of about 24,968 (201)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma

open access: yesFrontiers in Pharmacology, 2022
Background: Lenvatinib combined with a PD-1 inhibitor has obtained a satisfactory antitumor effect in several solid tumors. However, the efficacy and tumor response of lenvatinib with a PD-1 inhibitor in advanced intrahepatic cholangiocarcinoma still ...
Lulu Xie   +10 more
doaj   +1 more source

Serum Markers of Intrahepatic Cholangiocarcinoma [PDF]

open access: yesDisease Markers, 2013
Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates in the bile duct epithelium. It is an aggressive malignancy typified by unresponsiveness to chemotherapy and radiotherapy. Despite advances in radiologic techniques and laboratory diagnostic test, the diagnosis of CCA remains highly challenging.
MALAGUARNERA, GIULIA ANNA MARIA   +5 more
openaire   +2 more sources

Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma

open access: yesCancer Medicine, 2018
Intrahepatic cholangiocarcinoma is a highly fatal tumor characterized by an abundant stromal environment. Cancer‐associated fibroblasts play key roles in tumor growth and invasiveness and have been regarded as a potential therapeutic target.
Meng Sha   +7 more
doaj   +1 more source

Mass-forming intrahepatic cholangiocarcinoma presenting with painful obstructive hemobilia

open access: yesJournal of the Belgian Society of Radiology, 2014
We report a very rare case of acute obstructive hemobilia caused by bleeding of a mass-forming intrahepatic cholangiocarcinoma in a 75-year old man. The prompt complete emergency diagnosis was made by ultrasound and confirmed by MDCT.
B Coulier   +3 more
doaj   +1 more source

Clear cell papillary cholangiocarcinoma: A case report with review of literature

open access: yesIndian Journal of Pathology and Microbiology, 2014
Clear cell papillary cholangiocarcinoma is a rare variant of intrahepatic cholangiocarcinoma with only nine reported cases in the literature. This tumor needs to be differentiated from clear cell variant of hepatocellular carcinoma and other metastatic ...
Rachna Khera   +3 more
doaj   +1 more source

INTRAHEPATIC CHOLANGIOCARCINOMA

open access: yesClinical and Experimental Morphology
Intrahepatic cholangiocarcinoma (ICC) is a rare but aggressive malignancy arising from the epithelial cells of the intrahepatic bile ducts. The disease is characterized by complex diagnosis, high mortality, and limited therapeutic options at advanced stages.
Banina E., Burgoci S.
  +6 more sources

Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?

open access: yesSurgery Open Science, 2020
Background: The potential benefit of surgical resection of intrahepatic cholangiocarcinoma in patients with locoregionally advanced disease has not been definitively determined.
Patrick J. Sweigert, MD   +7 more
doaj   +1 more source

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian   +6 more
wiley   +1 more source

Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study

open access: yesEuropean Radiology Experimental
Prostate-specific membrane antigen (PSMA) targeted tracers show increased uptake in several malignancies, indicating a potential for peptide radioligand therapy. Intra-arterial injection of radiotracers can increase the therapeutic window.
Mara Marieke Katrien Veenstra   +6 more
doaj   +1 more source

Gut‐Liver Translocation of Bacteroides Uniformis Alleviates Advanced Metabolic Dysfunction‐Associated Steatotic Liver Disease by Suppressing Hepatocyte Ferroptosis via Propionic Acid Secretion

open access: yesAdvanced Science, EarlyView.
Systematic characterization of the liver‐resident microbiota in advanced metabolic dysfunction‐associated steatotic liver disease (MASLD) reveals a consistent depletion of Bacteroides uniformis (B. uniformis) in both hepatic and gut microbial communities. Oral gavage of B.
Haiyang Liu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy